On March 7, 2022, The Office of Advocacy of the U.S. Small Business Administration submitted the following comments on the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Service’s proposed rule to revise the Medicare Advantage (Part C) program, and the Medicare Prescription Drug Benefit (Part D) program.
Comments are closed.